Cours StemCells Inc Nasdaq
Actions
US85857R3030
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 13,97 M 12,66 M |
---|---|---|---|---|---|
Résultat net 2024 * | - | Résultat net 2025 * | - | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,32% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02/08/88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01/01/22 |
Chief Tech/Sci/R&D Officer | - | 01/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28/11/16 |
Director/Board Member | 66 | 12/12/17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01/08/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+22,81% | 46,81 Md | |
-1,88% | 41,37 Md | |
+47,13% | 41,29 Md | |
-6,20% | 28,87 Md | |
+11,33% | 26,06 Md | |
-21,00% | 19,13 Md | |
+30,73% | 12,39 Md | |
-0,48% | 12,08 Md | |
-1,43% | 11,96 Md |